STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Charles River Laboratories (CRL): Schedule 13G/A ownership update. Wellington Management Group LLP and affiliated entities filed Amendment No. 2 reporting beneficial ownership of 3,190,467 shares of CRL common stock, representing 6.48% of the class as of the event date 09/30/2025. The filing indicates shared voting and shared dispositive power across Wellington entities, with no sole voting or dispositive power reported.

The certification states the shares were acquired and are held in the ordinary course and not for the purpose of changing or influencing control. The securities are held of record by clients of Wellington’s advisory affiliates, and no such client is known to hold more than five percent of the class.

Positive
  • None.
Negative
  • None.

Insights

Wellington reports a passive 6.48% CRL stake.

Wellington and affiliates disclosed beneficial ownership of 3,190,467 CRL shares on a Schedule 13G/A, signaling a passive filing status. The group reports shared voting and dispositive power and no sole authority, consistent with institutional asset management on behalf of clients.

The certification confirms ordinary-course investing and no intent to influence control, aligning with a 13G profile. Because holdings are spread across advisory clients and no single client exceeds five percent, concentration risk appears limited in this excerpt.

Actual market impact depends on holder decisions and future ownership changes; subsequent filings may provide updated percentages or share counts.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:11/12/2025
Wellington Group Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:11/12/2025
Wellington Investment Advisors Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:11/12/2025
Wellington Management Company LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:11/12/2025

FAQ

What did Wellington disclose about CRL (NASDAQ: CRL) in this Schedule 13G/A?

Wellington reported beneficial ownership of 3,190,467 shares of CRL, representing 6.48% of the class.

Is the Wellington stake in CRL passive or active?

The certification states the shares were acquired and held in the ordinary course and not to change or influence control, indicating a passive position.

What is the event date for Wellington’s CRL ownership information?

The event date is 09/30/2025.

Who holds the CRL shares reported by Wellington?

The shares are owned of record by clients of Wellington’s investment adviser affiliates.

Does any single Wellington client hold more than 5% of CRL?

No. The filing states no such client is known to hold more than five percent of the class.

Which Wellington entities are listed in the filing?

Entities include Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP.

What voting and dispositive powers are reported?

Wellington entities report shared voting and shared dispositive power, with no sole power reported.
Charles Riv Labs Intl Inc

NYSE:CRL

CRL Rankings

CRL Latest News

CRL Latest SEC Filings

CRL Stock Data

8.33B
48.60M
1%
105.66%
5.42%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
WILMINGTON